Dual-Platform Evaluation of Charge-Modulated Betanin Delivery Using Cellular and Organismal Models

Betanin has potential for modulating lipid accumulation, but its biological activity depends on formulation and exposure conditions. We evaluated charge-modulated betanin liposomes in free fatty acid (FFA)-treated HepG2 cells and high-glucose-exposed Caenorhabditis elegans. Increasing DOTAP content from 0 to 30 mol% raised the zeta potential from −3.24 ± 0.12 to 31.09 ± 1.22 mV and the encapsulation efficiency from 35.21 ± 1.85% to 50.05 ± 1.70%. NBD-CL2 produced approximately 156-fold higher cell-associated fluorescence than NBD-CL0 in HepG2 cells, with higher fluorescence also observed descriptively in C. elegans. At the efficacy concentrations (25 μM betanin-equivalent in HepG2 cells and 50 μM in C. elegans), no apparent reduction in cell viability or survival was observed; pooled worm body-length measurements showed no overt change but did not support inference among independent exposure wells. In analyses accounting for experimental run, Bet-CL2 reduced Oil Red O intensity by 33.0% relative to the FFA-treated HepG2 group (n = 4 runs; Dunnett-adjusted p = 0.0061) and by 36.4% relative to the high-glucose C. elegans group (n = 3 runs; adjusted p = 0.017). These separate within-model results support attenuation of lipid accumulation in both models under the tested conditions, but do not establish cross-model statistical equivalence or superiority over free betanin or neutral liposomes. Carrier-associated fluorescence does not directly quantify betanin delivery. The dual-model approach supports complementary evaluation of carrier association and functional responses.

Authors

Institutions

Publication Details

Journal
Nanomaterials
Published
2026-11-18
DOI
https://doi.org/10.3390/nano16221492
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual-Platform Evaluation of Charge-Modulated Betanin Delivery Using Cellular and Organismal Models

Tae‐Joon Jeon, Sunhee Yoon, Sun Min Kim, EunHye Kim
4 links
Nanomaterials
Nanoparticle-Based Drug Delivery
article

Dual-Platform Evaluation of Charge-Modulated Betanin Delivery Using Cellular and Organismal Models

Tae‐Joon Jeon, Sunhee Yoon, Sun Min Kim, EunHye Kim
article en

Abstract

Betanin has potential for modulating lipid accumulation, but its biological activity depends on formulation and exposure conditions. We evaluated charge-modulated betanin liposomes in free fatty acid (FFA)-treated HepG2 cells and high-glucose-exposed Caenorhabditis elegans. Increasing DOTAP content from 0 to 30 mol% raised the zeta potential from −3.24 ± 0.12 to 31.09 ± 1.22 mV and the encapsulation efficiency from 35.21 ± 1.85% to 50.05 ± 1.70%. NBD-CL2 produced approximately 156-fold higher cell-associated fluorescence than NBD-CL0 in HepG2 cells, with higher fluorescence also observed descriptively in C. elegans. At the efficacy concentrations (25 μM betanin-equivalent in HepG2 cells and 50 μM in C. elegans), no apparent reduction in cell viability or survival was observed; pooled worm body-length measurements showed no overt change but did not support inference among independent exposure wells. In analyses accounting for experimental run, Bet-CL2 reduced Oil Red O intensity by 33.0% relative to the FFA-treated HepG2 group (n = 4 runs; Dunnett-adjusted p = 0.0061) and by 36.4% relative to the high-glucose C. elegans group (n = 3 runs; adjusted p = 0.017). These separate within-model results support attenuation of lipid accumulation in both models under the tested conditions, but do not establish cross-model statistical equivalence or superiority over free betanin or neutral liposomes. Carrier-associated fluorescence does not directly quantify betanin delivery. The dual-model approach supports complementary evaluation of carrier association and functional responses.

NanomaterialsVol. 16(22)
Inha University (KR)
Inha University
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon